- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00233701
Normal Pressure Hydrocephalus (NPH) Registry
February 5, 2010 updated by: Codman & Shurtleff
The overall aim of the registry is to develop a longitudinal, observational database that is focused on adult patients with Normal Pressure Hydrocephalus (NPH) that can be used as a source of clinical information for individual surgeons, as well as a national data repository for scientific inquiry and publications.
Study Overview
Status
Completed
Conditions
Detailed Description
This is a prospective, multi-center, observational database to collect data on the characteristics, management practices, and patient outcomes of NPH patients.
It will be offered to a geographically representative group of U.S. physicians who will enroll NPH patients.
The physician makes his/her own clinical decisions; thus, the data captured provides current practice patterns related to diagnosis, management, and results.
The registry may also assist physicians in patient follow-up and certain practice management tasks.
The data collected will serve to inform the medical community on optimal care for this patient population
Study Type
Observational
Enrollment (Actual)
343
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States
-
-
California
-
Los Angeles, California, United States
-
-
Colorado
-
Boulder, Colorado, United States
-
-
Florida
-
Jacksonville, Florida, United States
-
-
Georgia
-
Macon, Georgia, United States
-
-
Idaho
-
Boise, Idaho, United States
-
-
Illinois
-
Chicago, Illinois, United States
-
-
Iowa
-
Iowa City, Iowa, United States
-
-
Kentucky
-
Lexington, Kentucky, United States
-
-
Michigan
-
Detroit, Michigan, United States
-
-
New Jersey
-
Camden, New Jersey, United States
-
-
North Carolina
-
Charlotte, North Carolina, United States
-
Winston-Salem, North Carolina, United States
-
-
Ohio
-
Youngstown, Ohio, United States
-
-
Oklahoma
-
Midwest City, Oklahoma, United States
-
-
Oregon
-
Medford, Oregon, United States
-
Portland, Oregon, United States
-
-
Pennsylvania
-
Abington, Pennsylvania, United States
-
Hershey, Pennsylvania, United States, 17033
-
Johnson, Pennsylvania, United States
-
Pittsburgh, Pennsylvania, United States
-
-
Tennessee
-
Kingsport, Tennessee, United States
-
-
Texas
-
Dallas, Texas, United States
-
Wichita Falls, Texas, United States
-
-
Utah
-
Payson, Utah, United States
-
Salt Lake City, Utah, United States
-
-
Virginia
-
Richmond, Virginia, United States, 23298-0449
-
-
Wisconsin
-
LaCrosse, Wisconsin, United States
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
NPH patient who is a candidate for a shunt.
Can not be under that age of 18, have a known contraindication for a shunt, or have an expected life span of less than 24 months.
Description
Inclusion Criteria:
- Patient meets the diagnosis criteria for Normal Pressure Hydrocephalus
- Patient is a candidate for a hydrocephalus shunt system, per the discretion of the investigator
- Patient or legal representative has signed an informed consent form. Competency to sign the consent form will be left up to the discretion of the investigator
Exclusion Criteria:
- Patient is under the age of 18 years
- Patient has a known contraindication for a shunt
- Patient has an expected life span of less than 24 months
- Patient has an unwillingness or inability to return for required follow-up visits
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Database to describe the population of patients with NPH presenting for treatment (assessed at baseline/no safety assessment)
Time Frame: End of trial
|
End of trial
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To determine frequency of the various treatments for NPH and the outcomes of those treatment (assessed during surgery and at follow-up/no safety assessment)
Time Frame: End of trial
|
End of trial
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Anthony Marmarou, Ph.D., Virginia Commonwealth University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2004
Primary Completion (ACTUAL)
September 1, 2008
Study Completion (ACTUAL)
September 1, 2008
Study Registration Dates
First Submitted
October 4, 2005
First Submitted That Met QC Criteria
October 4, 2005
First Posted (ESTIMATE)
October 6, 2005
Study Record Updates
Last Update Posted (ESTIMATE)
February 8, 2010
Last Update Submitted That Met QC Criteria
February 5, 2010
Last Verified
October 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NPH-US04-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Pressure Hydrocephalus
-
Umeå UniversityCompletedIdiopathic Normal Pressure Hydrocephalus
-
Uppsala University HospitalUppsala University; Swedish Society for Medical ResearchRecruitingIdiopathic Normal Pressure Hydrocephalus (INPH)Sweden
-
Johns Hopkins UniversityUniversity of Utah; Integra LifeSciences CorporationCompletedIdiopathic Normal Pressure Hydrocephalus (INPH)United States, Canada, Sweden
-
Mayo ClinicTerminatedNormal Pressure Hydrocephalus PatientsUnited States
-
Umeå UniversityCompleted
-
Dokuz Eylul UniversityRecruitingNPH (Normal Pressure Hydrocephalus)Turkey
-
University of ZurichRecruitingIdiopathic Normal Pressure HydrocephalusSwitzerland
-
Second Affiliated Hospital, School of Medicine,...Westlake UniversityUnknownIdiopathic Normal Pressure HydrocephalusChina
-
Translational Research Center for Medical Innovation...Johnson & Johnson; Codman & Shurtleff; Eisai Limited; Nihon Medi-Physics Co., Ltd. and other collaboratorsCompletedIdiopathic Normal Pressure HydrocephalusJapan
-
Johns Hopkins UniversityNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingIdiopathic Normal Pressure Hydrocephalus (INPH)United States, Canada, Sweden